Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Awsare Saleel | President & CEO, Director | C/O LANTRONIX, INC., 48 DISCOVERY, SUITE 250, IRVINE | /s/ Brent Stringham, Attorney-in-fact for Saleel Awsare | 2025-07-15 | 0001733464 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LTRX | Restricted Stock Units | Award | $0 | +172K | $0.00 | 172K | Jul 11, 2025 | Common Stock | 172K | Direct | F1 |
Id | Content |
---|---|
F1 | The restricted stock units ("RSUs") shall vest such that one-third (1/3) of the shares vest on July 11, 2026 and the remaining two-thirds (2/3) of the total number of shares vest quarterly thereafter beginning on September 1, 2026, such that one hundred percent (100%) of the RSUs will be fully vested on June 1, 2028. |